WebLong-term results of use of bisphosphonates for patients with osteoporosis have been reported; they were 10 years for alendronate, 71 7 years for risedronate, 72 and 9 years for zoledronate. 73 However, the 3-year results for BMDs and bone turnover changes, vertebral fracture incidence, and adverse events were from the longest follow-up for minodronate. Web9 de jan. de 2007 · Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear,...
UpToDate
WebResults: The obtained data indicate that 10-year ALN use results in minimal, transient bone tissue composition changes compared to use for 5 years, confined to actively forming … Web28 de abr. de 2024 · Long-term bisphosphonate therapy Adults who have been taking zoledronic acid for 3 years or alendronate, ibandronate or risedronate for 5 years should … darty offre remboursement
Atypical femoral fracture after long-term alendronate treatment: Report ...
Web20 de mai. de 2010 · Alendronate is indicated for the treatment and prevention of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, osteoporosis in men, and Paget’s disease. 21 Alendronate is eliminated unchanged by the kidney, and a dose adjustment is indicated at CrCl <35 mL/min. Wetmore et al studied the effects of short … Web21 de jul. de 2024 · Alendronate has been shown to be effective in Black American women [ 12] and in older women in long-term care facilities [ 13,14 ]. Risedronate – Risedronate improves BMD and reduces fracture risk in postmenopausal osteoporosis [ 15-21 ]. Web1 de jan. de 2005 · Request PDF On Jan 1, 2005, Ian R Reid published Long-term use of alendronate Find, read and cite all the research you need on ResearchGate darty ollioules horaires